Clearance Summary
HUMAN CAERULOPLASMIN KIT received FDA 510(k) clearance under submission number K122965, sponsored by The Binding Site Group , Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2013-06-03.
- Submission: K122965
- Applicant / Sponsor: The Binding Site Group , Ltd.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5210
- Decision date: 2013-06-03
Classification & Regulation
This clearance is catalogued under FDA product code DDB and 21 CFR 866.5210, within the Immunology review panel as a Class II device.